STAT

Opinion: Trump is trying to end secret health care price negotiations. You should be on his side

The Trump administration's efforts in health care price transparency should be supported and furthered to help reveal — and begin to repair — cracks in the health care system that…

President Trump signed an executive order in June that could force price disclosure in health care. Insurers, doctors, and hospitals would have to reveal the secretly negotiated rates they pay for services or charge for them. A month later, the Centers for Medicare and Medicaid Services proposed a rule requiring hospitals to make more price information publicly available. The lack of price transparency behind these efforts is the driving force behind my company — but even if it means taking attention away from what we’re doing, I wholeheartedly support these moves.

The order is part of a growing movement on the federal level to . While the executive order and the president who signed it don’t enjoy universal

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanofi Licensing Novavax’s Covid Shot, Moderna’s RSV Vaccine, And More
Sanofi said it has reached a licensing deal to sell Novavax’s Covid shot as well as to try to combine the vaccine with Sanofi’s own flu vaccine.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks